Treatment for glioblastoma (GBM)
Intended for US audiences only.
Optune® Novocure™
nCompass support for Optune®

nCompass support

nCompass support program

Complete support every step of the way

From the moment your doctor prescribes Optune, the nCompass support program will be there for you on your Optune treatment journey.

If you would like to speak to an Optune Expert, you can contact us via phone or email below.

Call us toll free, any time of day:
1-855-281-9301 (toll free)

When your doctor prescribes Optune

nCompass can help you navigate insurance coverage and financial assistance

Our experienced team has helped numerous patients and caregivers, in all different financial situations, get access to Optune. They may be able to help you by:

  • Working with your insurance provider to obtain coverage for Optune

  • Talking to you about financial assistance programs, which may be able to lower the cost of Optune therapy

  • Offering assistance through our Charitable Care Program, if your household income is less than $150,000. Certain conditions apply

When you’re ready to get started

nCompass will contact you to set up in-person training with a Device Support Specialist (DSS)

To help you get off to the right start, a DSS will come to your home* or doctor’s office to provide training to you and your caregivers on:

  • How to use the device

  • How to prepare your head

  • How to properly place transducer arrays

  • How to incorporate Optune into your life and daily activities

If you currently use Optune and have questions about switching to the second generation Optune System, contact nCompass.

Whenever you need it

nCompass provides ongoing support from your DSS, 24/7 technical support, and travel assistance

Your DSS will provide ongoing support by:

  • Checking in and continuing to answer questions about using Optune

  • Working with you to obtain your monthly compliance data. This is a record of how much time during the day you are actively receiving therapy

Technical support is available 24/7 to:

  • Provide additional supplies, like extra batteries or transducer arrays

  • Help troubleshoot the device and answer technical questions

If your doctor tells you that it is okay, travel may be possible with Optune. Contact nCompass for:

  • Assistance if you plan to travel with Optune

  • If you’re preparing for air travel with Optune, nCompass can work with you and your airline to make things go more smoothly

*Some circumstances may require device training to occur at another location.
International travel support from nCompass is dependent on Optune’s approval status in the destination country.

You’re not alone

Find out about national and local
advocacy groups.

Browse groups

Talk to someone with Optune experience

The Buddy Program can connect you with patients and caregivers who have used Optune and know what it’s like.

Connect now
Find a Treatment Center



Indications For Use

Optune is intended as a treatment for adult patients (22 years of age or older) with histologically-confirmed glioblastoma multiforme (GBM).

Optune with temozolomide is indicated for the treatment of adult patients with newly diagnosed, supratentorial glioblastoma following maximal debulking surgery and completion of radiation therapy together with concomitant standard of care chemotherapy.

For the treatment of recurrent GBM, Optune is indicated following histologically-or radiologically-confirmed recurrence in the supratentorial region of the brain after receiving chemotherapy. The device is intended to be used as a monotherapy, and is intended as an alternative to standard medical therapy for GBM after surgical and radiation options have been exhausted.

Important Safety Information


Do not use Optune if you have an active implanted medical device, a skull defect (such as, missing bone with no replacement), or bullet fragments. Use of Optune together with implanted electronic devices has not been tested and may theoretically lead to malfunctioning of the implanted device. Use of Optune together with skull defects or bullet fragments has not been tested and may possibly lead to tissue damage or render Optune ineffective.

Do not use Optune if you are known to be sensitive to conductive hydrogels. In this case, skin contact with the gel used with Optune may commonly cause increased redness and itching, and rarely may even lead to severe allergic reactions such as shock and respiratory failure.

Warnings and Precautions

Use Optune only after receiving training from qualified personnel, such as your doctor, a nurse, or other medical personnel who have completed a training course given by Novocure (the device manufacturer).

Do not use Optune if you are pregnant, you think you might be pregnant or are trying to get pregnant. It is not known if Optune is safe or effective in these populations.

The most common (≥10%) adverse events involving Optune in combination with temozolomide were low blood platelet count, nausea, constipation, vomiting, fatigue, scalp irritation from device use, headache, convulsions, and depression.

The most common (≥10%) adverse events seen when using Optune alone were scalp irritation from device use and headache.

The following adverse reactions were considered related to Optune when using the device alone: scalp irritation from device use, headache, malaise, muscle twitching, fall and skin ulcer.

All servicing procedures must be performed by qualified and trained personnel.

Do not use any parts that do not come with the Optune Treatment Kit, or that were not sent to you by the device manufacturer or given to you by your doctor.

Do not wet the device or transducer arrays.

If you have an underlying serious skin condition on the scalp, discuss with your doctor whether this may prevent or temporarily interfere with Optune treatment.

Please click here to see the Optune Instructions For Use (IFU) for complete information regarding the device's indications, contraindications, warnings, and precautions.

Patient Journey videos on this site depict actual patients and caregivers. All other depictions of patients, caregivers, and healthcare professionals are actor portrayals.

Indications For Use

Optune is intended as a treatment for adult patients (22 years of age or older) with histologically-confirmed glioblastoma multiforme (GBM).